Literature DB >> 32417214

Circular RNAs in nasopharyngeal carcinoma.

Mingxiu Yang1, Weiguo Huang2.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a geographical distributed epithelial tumor of head and neck, which is prevalent in east Africa and Asia, especially southern China. Moreover, NPC has an unfavorable clinical effect and is prone to metastasis at an advanced stage. Although the recovery rate of patients has been improved due to concurrent chemoradiotherapy, poor curative effects and low overall survival remain key issues. The precise mechanisms and pivotal regulators of NPC remain still unclear. To improve the therapeutic efficacy, we focused on related-NPC circular RNAs (circRNAs). CircRNAs are a unique type of endogenous non-coding RNAs (ncRNAs) with a covalent closed-loop structure. Their expression is rich, stable and conservative. Different circRNA have specific tissue and developmental stages and can be detected in body fluids. In addition, circRNAs are involved in multiple pathological processes, especially in cancers. In recent years, using high-throughput indicator technology and bioinformatics technology, a large number of circRNAs have been identified in NPC cells and verified to have biological functions and mechanisms of action. This article aims to provide a retrospective review of the latest research on the proliferation and migration of related-NPC circRNA. Specifically, we focused on the roles and mechanisms of circRNAs in the development and progression of NPC.
CONCLUSION: CircRNA can act as an oncogene or tumor suppressor gene and participate in NPC progression (e.g., proliferation, apoptosis, migration, and invasion). In short, circRNAs have potential as biomarkers for the diagnosis, prognosis and treatment of NPC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Circular RNA; Invasion; Migration; Nasopharyngeal carcinoma (NPC); Proliferation

Mesh:

Substances:

Year:  2020        PMID: 32417214     DOI: 10.1016/j.cca.2020.05.029

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

Review 1.  Nasopharyngeal carcinoma: an evolving paradigm.

Authors:  Kenneth C W Wong; Edwin P Hui; Kwok-Wai Lo; Wai Kei Jacky Lam; David Johnson; Lili Li; Qian Tao; Kwan Chee Allen Chan; Ka-Fai To; Ann D King; Brigette B Y Ma; Anthony T C Chan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-30       Impact factor: 66.675

2.  Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway.

Authors:  Ruijie Liu; Ping Deng; Yonglian Zhang; Yonglan Wang; Cuiping Peng
Journal:  World J Surg Oncol       Date:  2021-02-17       Impact factor: 2.754

3.  A novel circRNA-miRNA-mRNA network reveals hsa-circ-0040039 as a biomarker for intervertebral disc degeneration.

Authors:  Jianhua Tang; Chenlin Zhang; Shengru Wang; Jianfeng Chen
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

4.  Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop.

Authors:  Yian Wang; Qijia Yan; Yongzhen Mo; Yuhang Liu; Yumin Wang; Shanshan Zhang; Can Guo; Fuyan Wang; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2022-02-28       Impact factor: 27.401

5.  LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma.

Authors:  Shuo Li; Mingxing Tang; Nan Zen; Junyi Liang; Xiao Xing; Danglin Huang; Fei Liu; Xiaomeng Zhang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

6.  The Regulation of circRNA RNF13/miRNA-1224-5p Axis Promotes the Malignant Evolution in Acute Myeloid Leukemia.

Authors:  Rong Zhang; Yingchun Li; Hongtao Wang; Ke Zhu; Guojun Zhang
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

7.  Overexpressed circRANBP17 acts as an oncogene to facilitate nasopharyngeal carcinoma via the miR-635/RUNX2 axis.

Authors:  Minghui Zhou; Puwen Zhang; Yulin Zhao; Rui Liu; Yujie Zhang
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.